surmount-1 tirzepatide weight loss percent nejm 2022 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide for Obesity Treatment and

Zepbound is also used for moderate-to-severe OSA (Obstructive Sleep Apnea)

Prescription weight-loss drugs Zepbound, Semaglutide GLP-1, and Wegovy are intended to assist those who are struggling with weight loss

Precautions To be administered with caution to pregnant women, those wishing to become pregnant or those who are breastfeeding

This transition carries risk

If you have a history of eating disorders, you are entitled to a referral to both an eating disorders specialist and an obesity medicine specialist ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )

Este mecanismo no solo ayuda a perder grasa, sino que podra mejorar parmetros como el perfil lipdico y la presin arterial